AEON Biopharma, Inc. (NYSE AMERICAN: AEON) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT AEON BIOPHARMA, INC.

AEON Biopharma, Inc. (NYSE AMERICAN: AEON)
Listen to this Section


$0.72
+0.0309 ( +4.48% ) 23.3K

AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.

Market Data


Open $0.72
Previous Close $0.69
Volume 23.3K
Market Cap $19.07M
Day Range $0.69 - $0.73
52 Week Range $0.51 - $1.45
Shares Outstanding 26.31M
Change % +4.48%
Net Change ▲ 0.0309
Insider Ownership -0.10%
Exchange NYSE AMERICAN
SectorMiscellaneous
IndustryNone
IPO Year2023
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 110,000.00

Date Type Amount Purchased Purchaser
2025-05-23 Buy 60000.00 FISCHER JOST
2025-05-21 Buy 50000.00 FISCHER JOST

SEC Filings


Form Type Description Pages Date
8-k 8K-related 15 Nov 14, 2025
10-q Quarterly Reports 95 Nov 14, 2025
8-k 8K-related 137 Nov 13, 2025
8-k 8K-related 38 Sep 08, 2025
8-k 8K-related 15 Aug 12, 2025
10-q Quarterly Reports 68 Aug 12, 2025
8-k 8K-related 13 Jun 13, 2025
10-k/a Quarterly Reports 15 Jun 11, 2025
10-q/a Quarterly Reports 14 Jun 11, 2025

Latest News